E. A. Masson

3.0k total citations
66 papers, 2.2k citations indexed

About

E. A. Masson is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Neurology. According to data from OpenAlex, E. A. Masson has authored 66 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 14 papers in Physiology and 11 papers in Neurology. Recurrent topics in E. A. Masson's work include Diabetic Foot Ulcer Assessment and Management (13 papers), Pain Mechanisms and Treatments (10 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). E. A. Masson is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (13 papers), Pain Mechanisms and Treatments (10 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). E. A. Masson collaborates with scholars based in United Kingdom, United States and South Africa. E. A. Masson's co-authors include Andrew J.M. Boulton, Aristidis Veves, Devaka Fernando, Fiona Thomson, D. Fernando, P Renwick, Gerard Laden, Ahmed Abidia, A.R. Wilkinson and P.T. McCollum and has published in prestigious journals such as Diabetes Care, Gut and Pain.

In The Last Decade

E. A. Masson

66 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. A. Masson United Kingdom 26 1.2k 569 467 348 338 66 2.2k
Anders Stenström Sweden 28 1.0k 0.9× 611 1.1× 123 0.3× 427 1.2× 83 0.2× 67 2.3k
G. Menzinger Italy 24 720 0.6× 253 0.4× 215 0.5× 186 0.5× 135 0.4× 69 1.7k
C. Tsigos Greece 29 928 0.8× 232 0.4× 705 1.5× 102 0.3× 180 0.5× 43 2.5k
Kristien Van Acker Belgium 18 1.1k 0.9× 479 0.8× 201 0.4× 367 1.1× 47 0.1× 29 1.6k
Dominique Sigaudo‐Roussel France 22 267 0.2× 250 0.4× 434 0.9× 297 0.9× 96 0.3× 61 1.5k
César Calvo‐Lobo Spain 28 391 0.3× 147 0.3× 315 0.7× 102 0.3× 131 0.4× 230 3.0k
Ben F. Hurley United States 35 357 0.3× 420 0.7× 1.3k 2.9× 122 0.4× 57 0.2× 62 3.7k
Alexander Schnabel Germany 26 287 0.2× 264 0.5× 203 0.4× 129 0.4× 84 0.2× 76 2.9k
Timo Pohjolainen Finland 27 322 0.3× 352 0.6× 128 0.3× 97 0.3× 68 0.2× 52 2.2k
Kristian Borg Sweden 30 161 0.1× 174 0.3× 442 0.9× 28 0.1× 528 1.6× 127 3.2k

Countries citing papers authored by E. A. Masson

Since Specialization
Citations

This map shows the geographic impact of E. A. Masson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. A. Masson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. A. Masson more than expected).

Fields of papers citing papers by E. A. Masson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. A. Masson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. A. Masson. The network helps show where E. A. Masson may publish in the future.

Co-authorship network of co-authors of E. A. Masson

This figure shows the co-authorship network connecting the top 25 collaborators of E. A. Masson. A scholar is included among the top collaborators of E. A. Masson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. A. Masson. E. A. Masson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masson, E. A., et al.. (2009). Myelodysplasia diagnosed during pregnancy with temporary haematological improvement after delivery. Journal of Obstetrics and Gynaecology. 29(7). 665–667. 1 indexed citations
2.
Toplak, Hermann, A. Hamann, Rema Moore, et al.. (2006). Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study. International Journal of Obesity. 31(1). 138–146. 60 indexed citations
3.
Lindow, Stephen W., et al.. (2004). Smell perception during early pregnancy: no evidence of an adaptive mechanism. BJOG An International Journal of Obstetrics & Gynaecology. 112(1). 57–62. 25 indexed citations
4.
Abidia, Ahmed, Gerard Laden, Ganesh Kuhan, et al.. (2003). The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: A double-blind randomised-controlled trial. European Journal of Vascular and Endovascular Surgery. 25(6). 513–518. 259 indexed citations
5.
Lindow, S. W., et al.. (2002). Development of an instrument to measure nausea and vomiting in pregnancy. Journal of Obstetrics and Gynaecology. 22(5). 481–485. 21 indexed citations
6.
Jayagopal, Vijay, et al.. (2001). Mortality following amputation in diabetes. Diabetic Medicine. 18. 1 indexed citations
7.
Wilcox, David S., et al.. (1997). Immunohistochemical methods for semiquantitative analysis of collagen content in human peripheral nerve. Journal of Anatomy. 191(3). 367–374. 22 indexed citations
8.
Atkin, Stephen L., S. W. Lindow, C. Walton, & E. A. Masson. (1996). Recurrent Hypoglycaemia Associated with First and Second Trimester Insulin Sensitivity in a Patient with Insulin-dependent Diabetes. Diabetic Medicine. 13(6). 589–591. 5 indexed citations
9.
Savage, Matthew W., et al.. (1995). Effects of quinagolide (CV 205‐502), a selective D2‐agonist, on vascular reactivity in patients with a prolactin‐secreting adenoma. Clinical Endocrinology. 43(1). 49–53. 3 indexed citations
10.
Savage, Matthew W., Charles Bodmer, Adrian B Walker, et al.. (1995). Vascular reactivity to noradrenaline and neuropeptide Y in the streptozotocin‐induced diabetic rat. European Journal of Clinical Investigation. 25(12). 974–979. 12 indexed citations
11.
Atkin, Stephen L., E. A. Masson, & M. C. White. (1995). Isolated adrenocorticotropin deficiency presenting as primary infertility. Journal of Endocrinological Investigation. 18(6). 456–459. 7 indexed citations
12.
Masson, E. A., et al.. (1992). Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss.. Gut. 33(4). 563–564. 29 indexed citations
13.
Thomson, Fiona, et al.. (1991). Lack of Knowledge of Symptoms of Hypoglycaemia by Elderly Diabetic Patients. Age and Ageing. 20(6). 404–406. 64 indexed citations
14.
Veves, Aristidis, Rayaz A. Malik, R. H. Lye, et al.. (1991). The Relationship Between Sural Nerve Morphometric Findings and Measures of Peripheral Nerve Function in Mild Diabetic Neuropathy. Diabetic Medicine. 8(10). 917–921. 81 indexed citations
15.
Masson, E. A. & A. J. M. Boulton. (1990). Calibration Problems with the Biothesiometer. Diabetic Medicine. 7(3). 261–262. 6 indexed citations
16.
Veves, Aristidis, et al.. (1990). Studies of Experimental Hosiery in Diabetic Neuropathic Patients with High Foot Pressures. Diabetic Medicine. 7(4). 324–326. 51 indexed citations
17.
Masson, E. A., et al.. (1989). Split‐skin Grafting in the Management of Extensive Neuropathic Ulceration. Diabetic Medicine. 6(2). 171–172. 5 indexed citations
18.
Masson, E. A., et al.. (1989). The use of multiple insulin injection therapy using ‘NovoPenR’ in a routine out-patient setting. Diabetes Research and Clinical Practice. 7(1). 57–60. 6 indexed citations
19.
Masson, E. A., Aristidis Veves, D. Fernando, & Andrew J.M. Boulton. (1989). Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia. 32(10). 724–728. 141 indexed citations
20.
Masson, E. A., M. R. Clements, R Gokal, & A. J. M. Boulton. (1988). The need for a multi‐disciplinary approach to diabetic nephropathy. Practical Diabetes International. 5(6). 244–244. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anders Stenström Breakdown of academic impact, for papers by G. Menzinger Breakdown of academic impact, for papers by C. Tsigos Breakdown of academic impact, for papers by Kristien Van Acker Breakdown of academic impact, for papers by Dominique Sigaudo‐Roussel Breakdown of academic impact, for papers by César Calvo‐Lobo Breakdown of academic impact, for papers by Ben F. Hurley Breakdown of academic impact, for papers by Alexander Schnabel Breakdown of academic impact, for papers by Timo Pohjolainen Breakdown of academic impact, for papers by Kristian Borg
Rankless by CCL
2026